PIMALBA PIMALBA BENPIME BENPIME CEFSTAR CEFSTAR ELIPIME ELIPIME MAXIPIME MAXIPIME ZEPIM ZEPIM DAY PIME KC-PIME KC-PIME IDEZEM IDEZEM MEDIPIME MEDIPIME PERIN PERIN NEUPIME NEUPIME OBPIME OBPIME N-PIME SOPIME SOPIME CEFIPIME CEFIPIME CEFIPAR CEFIPAR PEFIPIME PEFIPIME WISEM WISEM PIMERA PIMERA PEFMAD PEFMAD FEBZIN FAPIZEN FAPIZEN CEPIME CEPIME SWISSPIME SWISSPIME VOCO VOCO BIOPIME BIOPIME ENDOPIME ENDOPIME BLUPINE BLUPINE CEFI CEFI CEFEP CEFEP VALFIPIME VALFIPIME OPIME OPIME NURECEF NURECEF ARPIM ARPIM AMIPIME AMIPIME EFFIPIME EFFIPIME PIMECEF PIMECEF PIMEZEB PIMEZEB BIOPRIM BIOPRIM CEF-4 CEF-4 PIME PIME EVERCEF EVERCEF PUNA PUNA MAXPIN MAXPIN PIMEMEG PIMEMEG USPIME USPIME CP-4 CP-4 GU-PIME GU-PIME JEWPIME JEWPIME MILKISH MILKISH LOWPIME LOWPIME NOVAPIME NOVAPIME SYNOPIME GRAY-PIME GRAY-PIME SHANTY SHANTY AQPINE AQPINE BACTIPIME BACTIPIME FELDOPIM FELDOPIM MEGAPIME MEGAPIME CEFGRAM CEFGRAM ELIDE ELIDE TRIPIM TRIPIM BIO NEX BIO NEX ZEYPIME ZEYPIME ARK ARK UCEFORE UCEFORE FECI FECI ROSIPINE ROSIPINE GILPIME GILPIME CEFPAM CEFPAM LIN-PIME LIN-PIME W-PIME W-PIME MYPIME MYPIME ASTETIME ASTETIME ARAPIME ARAPIME Q QPIME DEXPIME DEXPIME ALSTAR AVEPIME AVEPIME AVETEK AVETEK AVETEK PIMON PIMON PIMESAVE PIMESAVE ALEEVA REFIPIME REFIPIME AFIPIME AFIPIME

Dose: 1000 to 2000 mg
Single Dose: 1500 (1500)
Frequency: 12 hourly
Route: IV/IM
Instructions:

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Cefepime (HCl) is the derivative of Cefepime. It is of Semi Synthetic origin and belongs to Cepheme Carboxylate. It belongs to Peptidoglycan synthesis inhibitor pharmacological group on the basis of mechanism of action and also classified in Antibiotic, Cephalosporin-4th Gen pharmacological group.The Molecular Weight of Cefepime is 571.50.

Cefepime is contraindicated in conditions like Hypersensitivity to any component of product.

The severe or irreversible adverse effects of Cefepime, which give rise to further complications include Pseudomembranous colitis, Hemolytic anemia, Bone marrow depression, Cholestasis, Hemorrhage, Hypoprothorombinemia.Cefepime produces potentially life-threatening effects which include Seizures, Encephalopathy. which are responsible for the discontinuation of Cefepime therapy.The symptomatic adverse reactions produced by Cefepime are more or less tolerable and if they become severe, they can be treated symptomatically, these include Vomiting, Abdominal cramps, Renal failure, Oral candidiasis.

Cefepime is primarily indicated in conditions like Neutropenia, Pneumonia, Pyelonephritis, Skin infections, Urinary tract infection.

No data regarding the interactions of Cefepime was found.

False +ve Direct Coombs Test False +ve Urinary Glucose Test (Clinitest)

Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Dry Powder for Inj Store at room temperature, Below 25°C or in refrigerator. Do not Freeze. Protect from Sunlight. Inj (reconstituted Soln) Store at room temperature, Between 20°C-25°C or in refrigerator. Use within 7 days if refrigerated and within 24 hrs if kept at room temperature.

Cefepime should be used with caution in patients with history of allergies, especially to penicillin, cephalosporins or any antibiotics, history of kidney disease, liver disease, seizure or colitis. It should be used with caution in the elderly patients, as kidney function is generally poor. It should be used with caution during pregnancy or lactation.